Established technology platforms of RT-PCR, chemiluminescence immunoassay and fluorescence immunoassay

Approved as Provincial High-tech Enterprise R&D Center

Approved as Hangzhou Patent Pilot Enterprise

Obtained US FDA 510(k) Clearances

Brand new R&D and production base completed

Obtained ISO 9001 quality management system certification

Approved as National High-tech Enterprise

Obtained CE certification and ISO 13485 medical device quality management system certification

Obtained China Medical Device Manufacturer License

Established technology platforms of colloidal gold immunoassay and ELISA

Clongene Biotech Co., Ltd. was established

Established technology platforms of genetic engineering, monoclonal antibody and polyclonal antibody